16:01 Dec 26
Beryl Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Beryl Drugs Ltd.
0/100 Not Eligible
Quality45/100 Mid Valuation
Valuation63/100 Technically Moderately Bullish
TechnicalSWOT
Strength
6
Weakness
8
Opportunity
0
Threat
0
18.89
Market Cap (Cr)
-
PE Ratio
2.04
Price to Book Ratio
52.7
RSI
6.21 %
Net Profit Margin
SWOT
Download Our App On:
